Vanda Pharmaceuticals Inc.
VNDA | NASDAQ
$5.20
+$0.04 (+0.87%)
Sep 22, 2026, 1:29 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -2.36 | -14.97 | 96.57 | 67.18 | 26.15 | 30.56 |
PEG Ratio | 0 | 0.02 | -1.60 | -0.82 | 0.66 | -0.38 |
PS Ratio | 2.41 | 1.40 | 1.26 | 1.64 | 3.24 | 2.88 |
PB Ratio | 1.59 | 0.52 | 0.44 | 0.79 | 1.73 | 1.58 |
P/FCF Ratio | -4.71 | -17.14 | 19.50 | 13.33 | 13.69 | 14.31 |
P/OCF Ratio | -4.75 | -17.68 | 18.92 | 13.05 | 13.57 | 13.81 |
OCF/S Ratio | -50.64 | -7.93 | 6.64 | 12.57 | 23.90 | 20.86 |
Debt / Equity Ratio | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 |
Quick Ratio | 2.38 | 4.37 | 4.92 | 5.67 | 6.41 | 6.19 |
Current Ratio | 2.39 | 4.39 | 4.94 | 5.68 | 6.43 | 6.21 |
Asset Turnover | 0.44 | 0.30 | 0.30 | 0.40 | 0.45 | 0.47 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -67.38% | -3.51% | 0.46% | 1.19% | 6.57% | 5.15% |
Return on Assets | -45.09% | -2.88% | 0.39% | 0.99% | 5.58% | 4.37% |
Return on Invested Capital | -43.27% | -5.98% | -0.98% | 0.64% | 6.33% | 4.28% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 93.96% | 94.31% | 92.32% | 90.45% | 90.46% | 90.59% |
Net Profit Margin | -102.02% | -9.51% | 1.30% | 2.47% | 12.34% | 9.40% |
Pretax Profit Margin | -64.16% | -11.53% | 3.29% | 4.44% | 15.77% | 12.76% |
Operating Profit Margin | -69.95% | -20.46% | -7.24% | 2.49% | 15.69% | 10.98% |
FCF Margin | -51.10% | -8.17% | 6.45% | 12.31% | 23.69% | 20.14% |
EBITDA Margin | -58.64% | -7.44% | 4.85% | 5.52% | 16.82% | 13.91% |
Add to Watchlist
Select watchlists to add or remove VNDA